The week's pharma news includes FDA warnings for Lilly and Novo, new drug approvals for MASH and edema, and a look ahead at CPHI Europe.

Finalists for CPHI Frankfurt Pharma Awards 2025 showcase innovation in drug development, advanced manufacturing, and future ...

Misleading promotions of GLP-1 and compounded semaglutide products are drawing renewed regulatory scrutiny over risk ...

The company, under parent ICE Pharma, will celebrate its past achievements, present its expertise and plans for the future, and unveil a “100 Years” logo.

Nevada-based Corstasis Therapeutics (Corstasis) has announced FDA’s approval of its bumetanide nasal spray, Enbumyst, for the ...

Novo Nordisk’s Wegovy will be competing with Madrigal Pharmaceuticals’ Rezdiffra in the metabolic dysfunction-associated ...

The two organizations are collaborating on an integrated translational biology platform for the development of ...

UK pharma small- and medium-sized enterprises face funding and R&D barriers. Improved tax relief and targeted incentives are ...

Merck’s Sanat Chattopadhyay called for stronger leadership, data-driven oversight, and shared accountability to raise ...

The company has expanded its CDMO offerings in recent years, adding to decades of experiences in solutions such as moisture management.

Charles Gibbons of Lachman Consultants and Michael Grischeau of AbbVie stressed AI governance, data integrity, and human ...

Susan J. Schniepp, Distinguished Fellow, Regulatory Compliance Associates, joins PDA CEO Glenn Wright and Melissa Seymour, ...